Medivie Therapeutic (Israel) Top Management

MDVI Stock  ILA 32.50  0.50  1.56%   
Medivie Therapeutic employs about 11 people. The company is managed by 10 executives with a total tenure of roughly 66 years, averaging almost 6.0 years of service per executive, having 1.1 employees per reported executive. Analysis of Medivie Therapeutic's management performance can provide insight into the company performance.
Itai Hecht  CEO
Chief Executive Officer of the Company’s Subsidiary
Menachem Cohen  CEO
Chief Executive Officer, Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medivie Therapeutic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Medivie Therapeutic Management Team Effectiveness

The company has return on total asset (ROA) of (1.0886) % which means that it has lost $1.0886 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5598) %, meaning that it generated substantial loss on money invested by shareholders. Medivie Therapeutic's management efficiency ratios could be used to measure how well Medivie Therapeutic manages its routine affairs as well as how well it operates its assets and liabilities.

Medivie Therapeutic Workforce Comparison

Medivie Therapeutic is considered to be number one stock in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is now estimated at about 25,525. Medivie Therapeutic adds roughly 11.0 in number of employees claiming only tiny portion of all equities under Medical Instruments & Supplies industry.

Medivie Therapeutic Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Medivie Therapeutic Price Series Summation is a cross summation of Medivie Therapeutic price series and its benchmark/peer.

Medivie Therapeutic Notable Stakeholders

A Medivie Therapeutic stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medivie Therapeutic often face trade-offs trying to please all of them. Medivie Therapeutic's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medivie Therapeutic's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Itai HechtChief Executive Officer of the Company’s SubsidiaryProfile
Menachem CohenChief Executive Officer, DirectorProfile
Uri BenOrVice President - FinanceProfile
Irit BenAmiExternal DirectorProfile
Yigal FatranExternal DirectorProfile
Eyal PaauwIndependent DirectorProfile
Omri WolfInternal AuditorProfile
Uri OrChief OfficerProfile
Pr MBBSChief ScientistProfile
Yigal HevroniChairman of the BoardProfile

About Medivie Therapeutic Management Performance

The success or failure of an entity such as Medivie Therapeutic often depends on how effective the management is. Medivie Therapeutic management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medivie management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medivie management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Medivie Therapeutic Limited develops and markets dental devices. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom. MEDIVIE THERP is traded on Tel Aviv Stock Exchange in Israel.
Please note, the presentation of Medivie Therapeutic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medivie Therapeutic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Medivie Therapeutic's management manipulating its earnings.

Medivie Therapeutic Workforce Analysis

Traditionally, organizations such as Medivie Therapeutic use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medivie Therapeutic within its industry.

Medivie Therapeutic Manpower Efficiency

Return on Medivie Therapeutic Manpower

Revenue Per Employee44.6K
Revenue Per Executive49.1K
Net Loss Per Employee599.5K
Net Loss Per Executive659.4K

Complementary Tools for Medivie Stock analysis

When running Medivie Therapeutic's price analysis, check to measure Medivie Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivie Therapeutic is operating at the current time. Most of Medivie Therapeutic's value examination focuses on studying past and present price action to predict the probability of Medivie Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivie Therapeutic's price. Additionally, you may evaluate how the addition of Medivie Therapeutic to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios